5-AminoindazoleCAS# 19335-11-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 19335-11-6 | SDF | Download SDF |
| PubChem ID | 88012 | Appearance | Powder |
| Formula | C7H7N3 | M.Wt | 133 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 1H-indazol-5-amine | ||
| SMILES | C1=CC2=C(C=C1N)C=NN2 | ||
| Standard InChIKey | XBTOSRUBOXQWBO-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C7H7N3/c8-6-1-2-7-5(3-6)4-9-10-7/h1-4H,8H2,(H,9,10) | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
5-Aminoindazole Dilution Calculator
5-Aminoindazole Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 7.5188 mL | 37.594 mL | 75.188 mL | 150.3759 mL | 187.9699 mL |
| 5 mM | 1.5038 mL | 7.5188 mL | 15.0376 mL | 30.0752 mL | 37.594 mL |
| 10 mM | 0.7519 mL | 3.7594 mL | 7.5188 mL | 15.0376 mL | 18.797 mL |
| 50 mM | 0.1504 mL | 0.7519 mL | 1.5038 mL | 3.0075 mL | 3.7594 mL |
| 100 mM | 0.0752 mL | 0.3759 mL | 0.7519 mL | 1.5038 mL | 1.8797 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Lonafarnib
Catalog No.:BCC2331
CAS No.:193275-84-2
- 1-O-Acetyl-6alpha-O-(2-methylbutyryl)britannilactone
Catalog No.:BCN7747
CAS No.:1932687-71-2
- cis-Moschamine
Catalog No.:BCN3901
CAS No.:193224-24-7
- Otamixaban
Catalog No.:BCC1827
CAS No.:193153-04-7
- Cardamonin
Catalog No.:BCN1184
CAS No.:19309-14-9
- CTS-1027
Catalog No.:BCC1502
CAS No.:193022-04-7
- ZM323881
Catalog No.:BCC2073
CAS No.:193001-14-8
- ZM 323881 HCl
Catalog No.:BCC5098
CAS No.:193000-39-4
- Ximelagatran
Catalog No.:BCC6382
CAS No.:192939-46-1
- LY310762
Catalog No.:BCC5052
CAS No.:192927-92-7
- 2-Amino-2'-nitrodiphenyl sulfide
Catalog No.:BCC8522
CAS No.:19284-81-2
- ES 936
Catalog No.:BCC6102
CAS No.:192820-78-3
- Co 101244 hydrochloride
Catalog No.:BCC7369
CAS No.:193356-17-1
- Tartrazine
Catalog No.:BCN2217
CAS No.:1934-21-0
- Zeylenone
Catalog No.:BCC8268
CAS No.:193410-84-3
- Fmoc-Glu(Edans)-OH
Catalog No.:BCC3491
CAS No.:193475-66-0
- Mulberroside F
Catalog No.:BCN2908
CAS No.:193483-95-3
- IPAG
Catalog No.:BCC5662
CAS No.:193527-91-2
- SB 239063
Catalog No.:BCC1923
CAS No.:193551-21-2
- Calcifediol
Catalog No.:BCC4949
CAS No.:19356-17-3
- GB 1b
Catalog No.:BCN7385
CAS No.:19360-72-6
- Terrestrosin K
Catalog No.:BCN2935
CAS No.:193605-07-1
- SB 216641 hydrochloride
Catalog No.:BCC6987
CAS No.:193611-67-5
- BRL-15572
Catalog No.:BCC5065
CAS No.:193611-72-2
Dispersion enhancing effect of sonochemically functionalized graphene oxide for catalysing antioxidant efficacy of curcumin.[Pubmed:28732937]
Ultrason Sonochem. 2017 Nov;39:208-217.
The non-hazardous sonochemical approach has been developed for the functionalization of graphene oxide (GrO) with 5-Aminoindazole (5-AIND). The formation of f-(5-AIND) GrO is confirmed with (13)C solid state NMR, HRXPS, XRD, Raman, TGA, DSC, FTIR etc. The >80% cell viabilities on MCF-7 and Vero cell lines have confirmed the high cytocompatibility of f-(5-AIND) GrO. Additionally, the morphological impact on Vero cell line has evidently confirmed the biocompatibility of f-(5-AIND) GrO. As compared to GrO, the f-(5-AIND) GrO has demonstrated an enhanced antioxidant efficacy of 69.4-72%, evaluated with 2, 2-diphenyl-1-picrylhydrazyl (DPPH) free radical assay. With a similar objective (0.01-0.05)mL peanut oil based curcumin micro and nanoemulsions have been prepared using ethanol and glycerol as co-solvent and co-surfactant respectively. The prepared emulsions are subsequently characterised with respect to morphological and physicochemical parameters via density, surface tension, viscosity, friccohesity measurement and DLS analysis. Henceforth, with an expectation to achieve higher dispersion, an ethanolic dispersion of f-(5-AIND) GrO has been mixed with curcumin carrying emulsions in 1:1. Notably, the radical scavenging activities (RSA) of the combined formulations are significantly enhanced to an extent of 26.6%.
